Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacobus Lubsen

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Heart Failure|November 3, 2006
The development of heart failure in patients with stable angina pectorisGeorge C Sutton, Jan Erik Otterstad, Bridget-Anne Kirwan, et al.
European Journal of Epidemiology|February 22, 2011
Long-term impact of secondary preventive treatments in patients with stable anginaZoltán Vokó, Sophie de Brouwer, Jacobus Lubsen, et al.
Scandinavian Cardiovascular Journal : SCJ|June 27, 2006
Incidence and outcome of atrial fibrillation in stable symptomatic coronary diseaseJan Erik Otterstad, Bridget-Anne Kirwan, Jacobus Lubsen, et al.
BMJ (Clinical Research Ed.)|October 8, 2005
Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patientsTim C Clayton, Jacobus Lubsen, Stuart J Pocock, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|April 10, 2007
Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION studyAnthony M Dart, Jan Erik Otterstad, Bridget-Anne Kirwan, et al.
Journal of Clinical Epidemiology|June 19, 2007
Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial dataPhilip A Poole-Wilson, Bridget-Anne Kirwan, Zoltán Vokó, et al.
Contemporary Clinical Trials|November 22, 2007
Quality management of a large randomized double-blind multi-centre trial: the ACTION experienceBridget-Anne Kirwan, Jacobus Lubsen, Sophie de Brouwer, et al.
The American Journal of Cardiology|March 30, 2010
Gender differences in cardiac remodeling and clinical outcomes in chronic stable angina pectoris (from the ACTION Trial)Bonnie Ky, Bridget-Anne Kirwan, Sophie de Brouwer, et al.
Journal of Hypertension|July 11, 2007
Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcomeLuis M Ruilope, Bridget-Anne Kirwan, Sophie de Brouwer, et al.
European Heart Journal|November 2, 2010
The future of clinical trials in secondary prevention after acute coronary syndromesHéctor Bueno, Paul W Armstrong, Martin J Buxton, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Heart Failure|November 3, 2006
The development of heart failure in patients with stable angina pectorisGeorge C Sutton, Jan Erik Otterstad, Bridget-Anne Kirwan, et al.
European Journal of Epidemiology|February 22, 2011
Long-term impact of secondary preventive treatments in patients with stable anginaZoltán Vokó, Sophie de Brouwer, Jacobus Lubsen, et al.
Scandinavian Cardiovascular Journal : SCJ|June 27, 2006
Incidence and outcome of atrial fibrillation in stable symptomatic coronary diseaseJan Erik Otterstad, Bridget-Anne Kirwan, Jacobus Lubsen, et al.
BMJ (Clinical Research Ed.)|October 8, 2005
Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patientsTim C Clayton, Jacobus Lubsen, Stuart J Pocock, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|April 10, 2007
Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION studyAnthony M Dart, Jan Erik Otterstad, Bridget-Anne Kirwan, et al.
Journal of Clinical Epidemiology|June 19, 2007
Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial dataPhilip A Poole-Wilson, Bridget-Anne Kirwan, Zoltán Vokó, et al.
Contemporary Clinical Trials|November 22, 2007
Quality management of a large randomized double-blind multi-centre trial: the ACTION experienceBridget-Anne Kirwan, Jacobus Lubsen, Sophie de Brouwer, et al.
The American Journal of Cardiology|March 30, 2010
Gender differences in cardiac remodeling and clinical outcomes in chronic stable angina pectoris (from the ACTION Trial)Bonnie Ky, Bridget-Anne Kirwan, Sophie de Brouwer, et al.
Journal of Hypertension|July 11, 2007
Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcomeLuis M Ruilope, Bridget-Anne Kirwan, Sophie de Brouwer, et al.
European Heart Journal|November 2, 2010
The future of clinical trials in secondary prevention after acute coronary syndromesHéctor Bueno, Paul W Armstrong, Martin J Buxton, et al.
Pageof 4